Russell Investments Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$572K Sell
163,092
-34,951
-18% -$112K ﹤0.01% 2448
2025
Q4
$541K Buy
198,043
+131,072
+196% +$303K ﹤0.01% 2465
2025
Q3
$145K Buy
66,971
+26,624
+66% +$62.9K ﹤0.01% 2913
2025
Q2
$69.4K Buy
40,347
+31,807
+372% +$79.1K ﹤0.01% 2908
2025
Q1
$28.4K Buy
8,540
+1,862
+28% +$9.6K ﹤0.01% 3033
2024
Q4
$49.4K Sell
6,678
-590
-8% -$5.47K ﹤0.01% 2830
2024
Q3
$68.2K Sell
7,268
-14,732
-67% -$140K ﹤0.01% 2727
2024
Q2
$176K Buy
22,000
+21,165
+2,535% +$227K ﹤0.01% 2511
2024
Q1
$12.4K Sell
835
-7,200
-90% -$83.8K ﹤0.01% 2825
2023
Q4
$65.3K Sell
8,035
-5,285
-40% -$27.7K ﹤0.01% 2609
2023
Q3
$60.6K Sell
13,320
-11,779
-47% -$76.9K ﹤0.01% 2721
2023
Q2
$177K Sell
25,099
-141,499
-85% -$1.01M ﹤0.01% 2493
2023
Q1
$1.02M Buy
166,598
+121,440
+269% +$838K ﹤0.01% 1955
2022
Q4
$289K Buy
45,158
+25,751
+133% +$201K ﹤0.01% 2475
2022
Q3
$184K Sell
19,407
-6,457
-25% -$74.5K ﹤0.01% 2561
2022
Q2
$284K Buy
25,864
+25,029
+2,997% +$328K ﹤0.01% 2457
2022
Q1
$13K Buy
+835
New +$12.9K ﹤0.01% 2699
2021
Q3
Sell
-11,073
Closed -$287K 3124
2021
Q2
$287K Sell
11,073
-10,291
-48% -$267K ﹤0.01% 2794
2021
Q1
$675K Buy
21,364
+10,420
+95% +$432K ﹤0.01% 2397
2020
Q4
$507K Hold
10,944
﹤0.01% 2422
2020
Q3
$360K Sell
10,944
-50,630
-82% -$1.55M ﹤0.01% 2540
2020
Q2
$1.69M Sell
61,574
-23,115
-27% -$760K ﹤0.01% 1739
2020
Q1
$2.53M Sell
84,689
-183
-0.2% -$4.85K 0.01% 1341
2019
Q4
$2.35M Buy
84,872
+36,520
+76% +$831K ﹤0.01% 1642
2019
Q3
$880K Buy
+48,352
New +$1.07M ﹤0.01% 2059
2017
Q4
Sell
-16,732
Closed -$130K 2978
2017
Q3
$130K Sell
16,732
-35,029
-68% -$222K ﹤0.01% 2740
2017
Q2
$380K Hold
51,761
﹤0.01% 2522
2017
Q1
$386K Buy
+51,761
New +$379K ﹤0.01% 2517

Other funds holding IOVA